Logo Image
|Slideshows|April 3, 2020

Psychiatric Times

  • Vol 37, Issue 3
  • Volume 37
  • Issue 3

In This Issue of Psychiatric Times: Volume 37, No 3

Author(s)Laurie Martin

Read the Psychiatric Times issue cover-to-cover, with a bonus PDF.

Articles in this issue

over 6 years ago

When Baby and OCD Are on Board Assessment and Treatment Issues

over 6 years ago

Treatment Nonadherence: An Epidemic Hidden in Plain Sight

over 6 years ago

Assassins in London and Washington Force Changes in the Insanity Defense

over 6 years ago

Dear Provider

over 6 years ago

Are We Making Any Progress in Treatment and Attitudes?

over 6 years ago

Managing Behavioral and Psychological Symptoms of Dementia

over 6 years ago

Understanding Long-Acting Injectable Antipsychotics for Better Treatment Adherence

over 6 years ago

Reframing Our Relationship With Pharma

over 6 years ago

We’ve Come a Long Way . . . Or Have We?

over 6 years ago

The New Game of Microbiology Clue: The Who, When, Where, and Why of the Novel Coronavirus

Related Content

Latest CME

Jersey City Psychiatry
In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Register now!
Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia
Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

View more
Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

View more
Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia
Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

View more